SPL 2.13% 9.6¢ starpharma holdings limited

BV article, page-3

  1. 380 Posts.
    lightbulb Created with Sketch. 2
    The study was supported by Symbiomix. Dr. Schwebke is a consultant for Symbiomix and receives funding from Alfa Wassermann and Starpharma, among others. Dr. Hillier is coprincipal investigator of the Microbicide Trials Network, sponsored by the National Institutes of Health
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.002(2.13%)
Mkt cap ! $39.58M
Open High Low Value Volume
9.6¢ 9.7¢ 9.5¢ $14.96K 155.3K

Buyers (Bids)

No. Vol. Price($)
2 67946 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 10731 2
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.